trending Market Intelligence /marketintelligence/en/news-insights/trending/Si7YiJSbKz6yBqoyPvELBA2 content esgSubNav
In This List

Organovo to market tissue testing service in Japan

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Organovo to market tissue testing service in Japan

Organovo Holdings Inc. engaged Cosmo Bio Co. Ltd. to market and distribute its NovoView preclinical services in Japan.

The company will work with Cosmo's drug discovery services team to further its 3D bioprinting technology for testing kidney and liver tissue.